219 related articles for article (PubMed ID: 11305067)
1. Superior vena cava obstruction: is stenting necessary?
Marcy PY; Magné N; Bentolila F; Drouillard J; Bruneton JN; Descamps B
Support Care Cancer; 2001 Mar; 9(2):103-7. PubMed ID: 11305067
[TBL] [Abstract][Full Text] [Related]
2. [Venous endoprosthesis. Palliative treatment of superior caval syndrome of neoplastic origin].
Marcy PY; Laurent F; Cazenave F; Drouillard J; Chevallier P; Gorin G; Maestro C; Grelet P; Bruneton JN
J Radiol; 1997 Mar; 78(3):209-14. PubMed ID: 9113147
[TBL] [Abstract][Full Text] [Related]
3. Brachiocephalic-superior vena cava metallic stenting in malignant superior vena cava obstruction.
Lau KY; Tan LT; Wong WW; Lee AS
Ann Acad Med Singap; 2003 Jul; 32(4):461-5. PubMed ID: 12968550
[TBL] [Abstract][Full Text] [Related]
4. Endovascular stenting for end-stage lung cancer patients with superior vena cava syndrome post first-line treatments - A single-center experience and literature review.
Kuo TT; Chen PL; Shih CC; Chen IM
J Chin Med Assoc; 2017 Aug; 80(8):482-486. PubMed ID: 28501315
[TBL] [Abstract][Full Text] [Related]
5. A retrospective stenting study on superior vena cava syndrome caused by lung cancer.
Wei S; Liu J; Li X; Song Z; Dong M; Zhao H; Zhao Q; Chen G; Chen J
Thorac Cancer; 2020 Jul; 11(7):1835-1839. PubMed ID: 32438532
[TBL] [Abstract][Full Text] [Related]
6. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
[TBL] [Abstract][Full Text] [Related]
7. Stenting in malignant vena caval obstruction.
Oudkerk M; Heystraten FM; Stoter G
Cancer; 1993 Jan; 71(1):142-6. PubMed ID: 8416711
[TBL] [Abstract][Full Text] [Related]
8. Endovascular stenting in neoplastic superior vena cava syndrome prior to chemotherapy or radiotherapy.
Bierdrager E; Lampmann LE; Lohle PN; Schoemaker CM; Schijen JH; Palmen FM; van der Heul C
Neth J Med; 2005 Jan; 63(1):20-3. PubMed ID: 15719848
[TBL] [Abstract][Full Text] [Related]
9. A review of endovascular stenting for superior vena cava syndrome in fibrosing mediastinitis.
Deshwal H; Ghosh S; Magruder K; Bartholomew JR; Montgomery J; Mehta AC
Vasc Med; 2020 Apr; 25(2):174-183. PubMed ID: 31804157
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous endovascular Y-stenting of a malignant superior vena cava and innominate vein obstruction.
Cordial R; Moussavian MR; Corvalan J; Görtz H; Teßarek J
Vasc Endovascular Surg; 2014 Jan; 48(1):77-9. PubMed ID: 24122722
[TBL] [Abstract][Full Text] [Related]
11. Endovascular Management of SVC Syndrome due to Fibrosing Mediastinitis-A Feasibility and Safety Analysis.
Majumdar S; Shoela R; Kim DJ; Ramaswamy R; Mani N; Salter A; Akinwande O
Vasc Endovascular Surg; 2018 Apr; 52(3):202-206. PubMed ID: 29433409
[TBL] [Abstract][Full Text] [Related]
12. Use of self-expanding vascular endoprostheses in superior vena cava syndrome.
García Mónaco R; Bertoni H; Pallota G; Lastiri R; Varela M; Beveraggi EM; Vassallo BC
Eur J Cardiothorac Surg; 2003 Aug; 24(2):208-11. PubMed ID: 12895609
[TBL] [Abstract][Full Text] [Related]
13. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.
Lanciego C; Chacón JL; Julián A; Andrade J; López L; Martinez B; Cruz M; García-García L
AJR Am J Roentgenol; 2001 Sep; 177(3):585-93. PubMed ID: 11517051
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous stenting of superior vena cava syndrome: a case report and review of the literature.
Hochrein J; Bashore TM; O'Laughlin MP; Harrison JK
Am J Med; 1998 Jan; 104(1):78-84. PubMed ID: 9528723
[TBL] [Abstract][Full Text] [Related]
15. Stenting in malignant obstruction of superior vena cava.
Shah R; Sabanathan S; Lowe RA; Mearns AJ
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):335-40. PubMed ID: 8751500
[TBL] [Abstract][Full Text] [Related]
16. The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.
Irace L; Martinelli O; Gattuso R; Mingoli A; Fiori E; Alunno A; Di Girolamo A; Crocetti D; Sapienza P
Ann R Coll Surg Engl; 2021 Apr; 103(4):296-301. PubMed ID: 33682470
[TBL] [Abstract][Full Text] [Related]
17. Stent placement in superior vena cava syndrome.
Courtheoux P; Alkofer B; Al Refaï M; Gervais R; Le Rochais JP; Icard P
Ann Thorac Surg; 2003 Jan; 75(1):158-61. PubMed ID: 12537210
[TBL] [Abstract][Full Text] [Related]
18. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of endovascular Z-configuration stenting for malignant versus nonmalignant caval obstruction.
Han TM; Bondarev S; Keller EJ; Vogelzang RL; Resnick SA
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):939-944. PubMed ID: 32414673
[TBL] [Abstract][Full Text] [Related]
20. Relief of superior vena cava syndrome due to fibrosing mediastinitis using the Palmaz stent.
Dodds GA; Harrison JK; O'Laughlin MP; Wilson JS; Kisslo KB; Bashore TM
Chest; 1994 Jul; 106(1):315-8. PubMed ID: 8020305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
